Tag: Health
Inside the Therapist’s Room: A Look at the 2024 Election
I stand before my bathroom mirror, trying to calm my breathing. It's the morning after the election, and I just found out the results an hour ago. I've rushed through my morning routine, feeling...
Eli Lilly to Test Obesity Medications for Alcohol and Drug Addiction: CEO Announces Study
Eli Lilly Breaks New Ground in Addiction Treatment Research Eli Lilly, the pharmaceutical giant behind the popular weight loss drug Zepbound, has made a groundbreaking announcement. The company is set to embark on a study...
Merck Expands Portfolio with Licensing of Chinese Cancer Drug
Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...
Zepbound: Eli Lilly’s Obesity Drug Approved for Sleep Apnea Treatment in U.S.
Zepbound: Eli Lilly's Obesity Drug Approved for Sleep Apnea Treatment in U.S. The Food and Drug Administration made a groundbreaking announcement on Friday, granting approval to Eli Lilly's obesity drug, Zepbound, for the treatment of...
FDA Plans to Ban Cold Medicine, Eisai’s Alzheimer’s Drug Sales, and More: Pharmalittle Update
As we approach the end of another workweek, it's time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on...
Ending 23andMe’s Drug Discovery Dream: What Went Wrong?
23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...
Pharmacies Sue GoodRx and PBMs for Illegal Reimbursement Fees
Three independent pharmacies recently took legal action against GoodRx, a company that offers a prescription drug discount card, as well as several pharmacy benefit managers (PBMs). These lawsuits allege that GoodRx and the PBMs...
GSK Withdraws from BIO, Signaling Major Setback for Lobbying Group
Pharmaceutical company GSK has announced its decision to leave the Biotechnology Innovation Organization (BIO), which is the largest trade group in the biotechnology industry. This move by GSK marks a significant setback for the...
Alzheimer’s Drug Reversal & Bavarian Nordic’s Trump Views: Pharmalittle Update
As the week comes to an end, it's time to start thinking about weekend plans. Whether it's tidying up, taking a trip to see a college campus, or catching up on reading, there are...
Analyze Trump’s Recent Health Appointments: What You Need to Know
President-elect Trump has recently made some key appointments in the health sector, including the FDA commissioner, CDC director, and surgeon general. These individuals have stirred up some controversy due to their backgrounds and previous...
High-Dose Wegovy Trial Shows Significant Weight Loss, But Misses Zepbound Mark
High-Dose Wegovy Trial Unveils Promising Results In a groundbreaking clinical trial conducted by Novo Nordisk, a high dose of their obesity drug Wegovy showed significant potential for weight loss among patients with obesity. Despite this...
Understanding the Urgency of the BIOSECURE Act for Biosecurity Measures
The BIOSECURE Act, a piece of legislation targeting Chinese biotechnology companies, has been the center of attention in Washington early this year. However, the fate of this bill hangs in the balance as Congress...
